DRIO · DarioHealth Corp. · Financials
$6.93
+0.35 (+5.32%)
At close · Sep 11
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 13, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$67.91M
Shares
9.80M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$22.36M
-17.3%
FY2025
Net Income
-$41.71M
+2.4%
FY2025
Gross Margin
56.64%
+7.6pp
FY2025
Operating Margin
-163.94%
+49.6pp
FY2025
Diluted EPS
$10.12
-17.5%
FY2025
Operating Cash Flow
-$25.94M
+32.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $21M | $22.36M | $27.04M | $20.35M | $27.66M | $20.51M | $7.58M | $7.56M | $7.39M | $5.17M | $2.8M | $823K | $51K | $0 | — | |
| $8.79M | $9.69M | $13.77M | $14.37M | $18M | $16.55M | $5.06M | $4.96M | $5.63M | $3.86M | $3.36M | $1.68M | $2.27M | $0 | — | |
| $12.21M | $12.67M | $13.27M | $5.98M | $9.66M | $3.96M | $2.51M | $2.6M | $1.77M | $1.31M | -$830K | -$855K | -$2.71M | $0 | — | |
| — | 56.64% | 49.06% | 29.4% | 34.91% | 19.32% | 33.17% | 34.36% | 23.87% | 25.36% | -29.61% | -103.89% | -5317.65% | — | — | |
| $10.45M | $13.79M | $24.18M | $20.25M | $19.65M | $17.22M | $4.43M | $3.69M | $3.68M | $3.3M | $2.15M | $2.57M | $3.94M | $4.91M | $1.5M | |
| $14.5M | $15.19M | $20.48M | $18.14M | $16.49M | $23.53M | $12.76M | $5.48M | $5.47M | $4.73M | $3.38M | $2.95M | $3.64M | $6.3M | $2.18M | |
| $1.88M | $2.83M | $6.1M | $4.51M | $4.36M | $4.18M | — | — | — | — | — | — | — | — | — | |
| $44.05M | $49.32M | $71.01M | $62.17M | $66.47M | $80.46M | $32.42M | $20.3M | $19.45M | $15.73M | $10.27M | $6.84M | $8.65M | $13.56M | — | |
| -$31.83M | -$36.66M | -$57.74M | -$56.19M | -$56.81M | -$76.49M | -$29.9M | -$17.71M | -$17.69M | -$14.42M | -$11.1M | -$7.7M | -$11.36M | -$13.56M | -$3.97M | |
| — | -163.94% | -213.55% | -276.09% | -205.42% | -372.9% | -394.71% | -234.22% | -239.22% | -278.9% | -396.04% | -935.36% | -22270.59% | — | — | |
| — | $3.02M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $712K | $943K | $1.12M | $1.87M | $506K | $44K | $61K | $16K | $0 | — | — | — | — | — | — | |
| -$3.37M | -$4.95M | $13.15M | -$3.17M | -$5.38M | -$235K | $458K | -$31K | -$115K | -$1.32M | $214K | $556K | -$1.52M | -$369K | -$1.71M | |
| -$35.2M | -$41.61M | -$44.6M | -$59.36M | -$62.19M | -$76.73M | -$29.45M | -$17.74M | -$17.8M | -$15.74M | -$10.89M | -$7.14M | $12.88M | $13.93M | $5.69M | |
| $468K | $105K | -$1.85M | $64K | $4000 | $32K | — | — | — | — | — | — | — | — | — | |
| -$35.67M | -$41.71M | -$42.75M | -$59.43M | -$62.19M | -$76.76M | -$29.45M | -$17.74M | -$17.8M | -$15.74M | -$10.89M | -$7.14M | -$12.88M | -$13.93M | -$5.69M | |
| — | -186.56% | -158.09% | -292% | -224.88% | -374.21% | -388.66% | -234.63% | -240.78% | -304.51% | -388.41% | -867.8% | -25249.02% | — | — | |
| -$57.61M | — | — | — | -$59.96M | -$67.52M | -$33.1M | -$20.89M | -$18.3M | -$16M | -$11.61M | -$7.3M | -$16.06M | -$13.93M | — | |
| -$45.28M | -$61.74M | -$40.98M | -$63.51M | -$63.84M | -$78.77M | — | — | — | — | — | — | — | -$13.93M | -$5.69M | |
| USD/shares | $5.81 | $10.12 | $12.27 | $38.60 | $50.80 | $81.40 | $80.20 | — | — | — | — | — | — | — | — |
| USD/shares | $5.81 | $10.12 | $12.27 | $38.60 | $50.80 | $81.40 | $80.20 | — | — | — | — | — | — | — | — |
| shares | — | 3.98M | 2.45M | 1.42M | 1.18M | 829.59K | 298.17K | 113.31K | 58.53K | 481.41K | 260.15K | 94.89K | 433.95K | 183.13K | 618.75K |
| shares | — | 3.98M | 2.45M | 1.42M | 1.18M | 829.59K | 298.17K | 113.31K | 58.53K | 481.41K | 260.15K | 94.89K | 433.95K | 183.13K | 618.75K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.24×
EV/EBIT
—
Peer median 43.98×
P/E (TTM)
—
Peer median 38.22×
Peer medians compare against the 23 similar-size Health Information Services companies (of 48 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Service | $14,929,000 | $20,197,000 | $13,084,000 | $17,859,000 | $2,085,000 | $1,809,000 |
| Hardware and Consumable Products | $7,430,000 | $6,843,000 | $7,268,000 | $9,797,000 | $18,428,000 | — |
| Commercial | — | — | — | $16,377,000 | $851,000 | — |
| Consumers | — | — | $8,293,000 | $11,279,000 | $19,662,000 | — |
| Development Services Per Exclusive Agreement | — | — | $4,592,000 | $5,506,000 | — | — |
| Development Services Per Exclusive Agreement Year One | — | — | — | $4,000,000 | — | — |
| Development Services Per Exclusive Agreement Year Three | — | — | $2,098,000 | — | — | — |
| Development Services Per Exclusive Agreement Year Two | — | — | $2,494,000 | $1,506,000 | — | — |
| National Health Plan Statement of Work Agreement | — | — | $962,000 | $1,778,000 | — | — |
| Sales Channel Business to Business to Consumer (B2B2C) | — | — | $5,005,000 | $3,593,000 | — | — |
| Sales Channel Strategic Partnerships | — | — | $7,054,000 | $12,784,000 | — | — |
| Product | — | — | — | — | $17,793,000 | $5,767,000 |
Key facts
CIK
1533998
CUSIP
23725P308
13F (30d)
15 filings
15 filers
Visit website
Investor relations